Corcept Therapeutics
CORT
#2106
Rank
NZ$16.61 B
Marketcap
NZ$154.79
Share price
3.03%
Change (1 day)
28.08%
Change (1 year)

Corcept Therapeutics (CORT) - Total debt

Total debt on the balance sheet as of March 2026 : NZ$17.08 Million

According to Corcept Therapeutics 's latest financial reports the company's total debt is NZ$17.08 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Corcept Therapeutics - Total debt on balance sheet (from 2003 to 2026)

Total debt by year

Year Total debt Change
2025-12-31NZ$10.54 M-14.26%
2024-12-31NZ$12.29 M5050.71%
2023-12-31NZ$0.23 M-86.74%
2022-12-31NZ$1.8 M133.78%
2021-12-31NZ$0.77 M-78.22%
2020-12-31NZ$3.53 M-31.2%
2019-12-31NZ$5.13 M
2018-12-31N/A
2016-12-31NZ$21.16 M-3.18%
2015-12-31NZ$21.86 M81.79%
2014-12-31NZ$12.02 M72.11%
2013-12-31NZ$6.98 M116.95%
2012-12-31NZ$3.22 M
2010-12-31N/A-100%
2009-12-31NZ$0 M-70.04%
2008-12-31NZ$0.02 M-27.17%
2007-12-31NZ$0.03 M-36.5%
2006-12-31NZ$0.05 M-24.54%
2005-12-31NZ$0.07 M
2003-12-31NZ$0.8 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
NZ$97.47 B 570,482.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$83.31 B 487,582.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$112.97 B 661,205.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$76.88 B 449,936.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$87.06 B 509,571.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$82.30 B 481,668.19%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
NZ$0.58 B 3,334.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ$0.54 B 3,083.51%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$2.55 B 14,838.26%๐Ÿ‡บ๐Ÿ‡ธ USA